{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T09:47:17Z","timestamp":1749548837408},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00101-020-00860-0","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T09:02:56Z","timestamp":1601542976000},"page":"204-212","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Individualisierter Einsatz von Levosimendan in der Herzchirurgie"],"prefix":"10.1007","volume":"70","author":[{"given":"T.","family":"Woehrle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mehringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Juchem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dashkevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Weis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sch\u00fcnemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Kilger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"860_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","volume":"46","author":"WT Abraham","year":"2005","unstructured":"Abraham\u00a0WT, Adams\u00a0KF, Fonarow\u00a0GC et al (2005) In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the acute decompensated heart failure national registry (ADHERE). J\u00a0Am Coll Cardiol 46:57\u201364","journal-title":"J Am Coll Cardiol"},{"key":"860_CR2","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/ejhf.1557","volume":"21","author":"T Ahmad","year":"2019","unstructured":"Ahmad\u00a0T, Miller\u00a0PE, McCullough\u00a0M et\u00a0al (2019) Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials. Eur J Heart Fail 21:1064\u20131078","journal-title":"Eur J Heart Fail"},{"key":"860_CR3","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.athoracsur.2011.06.017","volume":"92","author":"KD Algarni","year":"2011","unstructured":"Algarni\u00a0KD, Maganti\u00a0M, Yau\u00a0TM (2011) Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery: trends over 20\u00a0years. Ann Thorac Surg 92:1678\u20131684","journal-title":"Ann Thorac Surg"},{"key":"860_CR4","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00134-016-4249-z","volume":"42","author":"DT Andreis","year":"2016","unstructured":"Andreis\u00a0DT, Singer\u00a0M (2016) Catecholamines for inflammatory shock: a\u00a0Jekyll-and-Hyde conundrum. Intensive Care Med 42:1387\u20131397","journal-title":"Intensive Care Med"},{"key":"860_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2017.9973","volume":"318","author":"B Cholley","year":"2017","unstructured":"Cholley\u00a0B, Caruba\u00a0T, Grosjean\u00a0S et\u00a0al (2017) Effect of levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass: the LICORN randomized clinical trial. JAMA 318:548\u2013556","journal-title":"JAMA"},{"key":"860_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s13054-019-2674-4","volume":"23","author":"B Cholley","year":"2019","unstructured":"Cholley\u00a0B, Levy\u00a0B, Fellahi\u00a0JL et\u00a0al (2019) Levosimendan in the light of the results of the recent randomized controlled trials: an expert opinion paper. Crit Care 23:385","journal-title":"Crit Care"},{"key":"860_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1536\/ihj.14-231","volume":"56","author":"W Ding","year":"2015","unstructured":"Ding\u00a0W, Ji\u00a0Q, Shi\u00a0Y et\u00a0al (2015) Predictors of low cardiac output syndrome after isolated coronary artery bypass grafting. Int Heart\u00a0J 56:144\u2013149","journal-title":"Int Heart J"},{"key":"860_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/01.RES.77.1.107","volume":"77","author":"I Edes","year":"1995","unstructured":"Edes\u00a0I, Kiss\u00a0E, Kitada\u00a0Y et\u00a0al (1995) Effects of levosimendan, a\u00a0cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circ Res 77:107\u2013113","journal-title":"Circ Res"},{"key":"860_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/00005344-200209000-00001","volume":"40","author":"M Endoh","year":"2002","unstructured":"Endoh\u00a0M (2002) Mechanisms of action of novel cardiotonic agents. J\u00a0Cardiovasc Pharmacol 40:323\u2013338","journal-title":"J Cardiovasc Pharmacol"},{"key":"860_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ijcard.2016.07.202","volume":"222","author":"D Farmakis","year":"2016","unstructured":"Farmakis\u00a0D, Alvarez\u00a0J, Gal\u00a0TB et\u00a0al (2016) Levosimendan beyond inotropy and acute heart failure: evidence of pleiotropic effects on the heart and other organs: an expert panel position paper. Int J Cardiol 222:303\u2013312","journal-title":"Int J Cardiol"},{"key":"860_CR11","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/00005344-199805000-00013","volume":"31","author":"N Gruhn","year":"1998","unstructured":"Gruhn\u00a0N, Nielsen-Kudsk\u00a0JE, Theilgaard\u00a0S et al (1998) Coronary vasorelaxant effect of levosimendan, a\u00a0new inodilator with calcium-sensitizing properties. J\u00a0Cardiovasc Pharmacol 31:741\u2013749","journal-title":"J Cardiovasc Pharmacol"},{"key":"860_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/FJC.0000000000000551","volume":"71","author":"F Guarracino","year":"2018","unstructured":"Guarracino\u00a0F, Heringlake\u00a0M, Cholley\u00a0B et al (2018) Use of levosimendan in cardiac surgery: an update after the LEVO-CTS, CHEETAH, and LICORN trials in the light of clinical practice. J\u00a0Cardiovasc Pharmacol 71:1\u20139","journal-title":"J Cardiovasc Pharmacol"},{"key":"860_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00101-018-0433-6","volume":"67","author":"M Habicher","year":"2018","unstructured":"Habicher\u00a0M, Zajonz\u00a0T, Heringlake\u00a0M et al (2018) S3 guidelines on intensive medical care of cardiac surgery patients : hemodynamic monitoring and cardiovascular system-an update. Anaesthesist 67:375\u2013379","journal-title":"Anaesthesist"},{"key":"860_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1749-8090-5-29","volume":"5","author":"MA Hamad","year":"2010","unstructured":"Hamad\u00a0MA, van Straten\u00a0AH, Schonberger\u00a0JP et\u00a0al (2010) Preoperative ejection fraction as a\u00a0predictor of survival after coronary artery bypass grafting: comparison with a\u00a0matched general population. J\u00a0Cardiothorac Surg 5:29","journal-title":"J Cardiothorac Surg"},{"key":"860_CR15","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1053\/j.jvca.2013.03.027","volume":"27","author":"RW Harrison","year":"2013","unstructured":"Harrison\u00a0RW, Hasselblad\u00a0V, Mehta\u00a0RH et al (2013) Effect of levosimendan on survival and adverse events after cardiac surgery: a\u00a0meta-analysis. J\u00a0Cardiothorac Vasc Anesth 27:1224\u20131232","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"860_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/00005344-200104000-00003","volume":"37","author":"P Kaheinen","year":"2001","unstructured":"Kaheinen\u00a0P, Pollesello\u00a0P, Levijoki\u00a0J et al (2001) Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels. J\u00a0Cardiovasc Pharmacol 37:367\u2013374","journal-title":"J Cardiovasc Pharmacol"},{"key":"860_CR17","first-page":"268","volume":"77","author":"E Kilger","year":"2011","unstructured":"Kilger\u00a0E, Heyn\u00a0J, Beiras-Fernandez\u00a0A et al (2011) Stress doses of hydrocortisone reduce systemic inflammatory response in patients undergoing cardiac surgery without cardiopulmonary bypass. Minerva Anestesiol 77:268\u2013274","journal-title":"Minerva Anestesiol"},{"key":"860_CR18","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1056\/NEJMoa1616325","volume":"376","author":"G Landoni","year":"2017","unstructured":"Landoni\u00a0G, Lomivorotov\u00a0VV, Alvaro\u00a0G et\u00a0al (2017) Levosimendan for hemodynamic support after cardiac surgery. N\u00a0Engl J Med 376:2021\u20132031","journal-title":"N Engl J Med"},{"key":"860_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang\u00a0RM, Badano\u00a0LP, Mor-Avi\u00a0V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J\u00a0Am Soc Echocardiogr 28:1\u201339.e14","journal-title":"J Am Soc Echocardiogr"},{"key":"860_CR20","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1517\/13543784.10.5.955","volume":"10","author":"LA Lehtonen","year":"2001","unstructured":"Lehtonen\u00a0LA (2001) Levosimendan: a\u00a0parenteral calcium-sensitising drug with additional vasodilatory properties. Expert Opin Investig Drugs 10:955\u2013970","journal-title":"Expert Opin Investig Drugs"},{"key":"860_CR21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1053\/euhj.1997.0806","volume":"19","author":"J Lilleberg","year":"1998","unstructured":"Lilleberg\u00a0J, Nieminen\u00a0MS, Akkila\u00a0J et\u00a0al (1998) Effects of a\u00a0new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart\u00a0J 19:660\u2013668","journal-title":"Eur Heart J"},{"key":"860_CR22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/jocs.12562","volume":"30","author":"JY Lim","year":"2015","unstructured":"Lim\u00a0JY, Deo\u00a0SV, Rababa\u2019h\u00a0A et al (2015) Levosimendan reduces mortality in adults with left ventricular dysfunction undergoing cardiac surgery: a systematic review and meta-analysis. J\u00a0Card Surg 30:547\u2013554","journal-title":"J Card Surg"},{"key":"860_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/j.jvca.2016.05.029","volume":"31","author":"VV Lomivorotov","year":"2017","unstructured":"Lomivorotov\u00a0VV, Efremov\u00a0SM, Kirov\u00a0MY et al (2017) Low-cardiac-output syndrome after cardiac surgery. J\u00a0Cardiothorac Vasc Anesth 31:291\u2013308","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"860_CR24","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1056\/NEJMoa1616218","volume":"376","author":"RH Mehta","year":"2017","unstructured":"Mehta\u00a0RH, Leimberger\u00a0JD, van Diepen\u00a0S et\u00a0al (2017) Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N\u00a0Engl J Med 376:2032\u20132042","journal-title":"N Engl J Med"},{"key":"860_CR25","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1010-7940(03)00074-5","volume":"23","author":"P Michel","year":"2003","unstructured":"Michel\u00a0P, Roques\u00a0F, Nashef\u00a0SA et al (2003) Logistic or additive EuroSCORE for high-risk patients? Eur J Cardiothorac Surg 23:684\u2013687 (discussion 687)","journal-title":"Eur J Cardiothorac Surg"},{"key":"860_CR26","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/aas.13089","volume":"62","author":"MH Moller","year":"2018","unstructured":"Moller\u00a0MH, Granholm\u00a0A, Junttila\u00a0E et\u00a0al (2018) Scandinavian SSAI clinical practice guideline on choice of inotropic agent for patients with acute circulatory failure. Acta Anaesthesiol Scand 62:420\u2013450","journal-title":"Acta Anaesthesiol Scand"},{"key":"860_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/ACO.0000000000000157","volume":"28","author":"DV Nielsen","year":"2015","unstructured":"Nielsen\u00a0DV, Algotsson\u00a0L (2015) Outcome of inotropic therapy: is less always more? Curr Opin Anaesthesiol 28:159\u2013164","journal-title":"Curr Opin Anaesthesiol"},{"key":"860_CR28","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/ALN.0000000000000224","volume":"120","author":"DV Nielsen","year":"2014","unstructured":"Nielsen\u00a0DV, Hansen\u00a0MK, Johnsen\u00a0SP et al (2014) Health outcomes with and without use of inotropic therapy in cardiac surgery: results of a\u00a0propensity score-matched analysis. Anesthesiology 120:1098\u20131108","journal-title":"Anesthesiology"},{"key":"860_CR29","doi-asserted-by":"publisher","first-page":"E093","DOI":"10.1532\/hsf.2731","volume":"23","author":"A Omar","year":"2020","unstructured":"Omar\u00a0A, Eldegwy\u00a0M, Allam\u00a0M et\u00a0al (2020) Comparison of levosimendan versus IABP in patients with poor left ventricular function undergoing coronary artery bypass graft surgery. Heart Surg Forum 23:E93\u2013E97","journal-title":"Heart Surg Forum"},{"key":"860_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijcard.2011.07.022","volume":"159","author":"Z Papp","year":"2012","unstructured":"Papp\u00a0Z, Edes\u00a0I, Fruhwald\u00a0S et\u00a0al (2012) Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan. Int J Cardiol 159:82\u201387","journal-title":"Int J Cardiol"},{"key":"860_CR31","doi-asserted-by":"publisher","first-page":"28584","DOI":"10.1016\/S0021-9258(19)61945-9","volume":"269","author":"P Pollesello","year":"1994","unstructured":"Pollesello\u00a0P, Ovaska\u00a0M, Kaivola\u00a0J et\u00a0al (1994) Binding of a\u00a0new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. J\u00a0Biol Chem 269:28584\u201328590","journal-title":"J Biol Chem"},{"key":"860_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0022-5223(96)70176-9","volume":"112","author":"V Rao","year":"1996","unstructured":"Rao\u00a0V, Ivanov\u00a0J, Weisel\u00a0RD et\u00a0al (1996) Predictors of low cardiac output syndrome after coronary artery bypass. J\u00a0Thorac Cardiovasc Surg 112:38\u201351","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"860_CR33","doi-asserted-by":"publisher","first-page":"645","DOI":"10.23736\/S0375-9393.20.14219-6","volume":"86","author":"F Sangalli","year":"2020","unstructured":"Sangalli\u00a0F, Bellani\u00a0G, Affronti\u00a0A et\u00a0al (2020) Levosimendan to facilitate weaning from cardiorespiratory support in critically ill patients: current evidence and future directions. Minerva Anestesiol 86(6):645\u2013651. https:\/\/doi.org\/10.23736\/S0375-9393.20.14219-6","journal-title":"Minerva Anestesiol"},{"key":"860_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2174\/157489011794578482","volume":"6","author":"P Scheiermann","year":"2011","unstructured":"Scheiermann\u00a0P, Beiras-Fernandez\u00a0A, Mutlak\u00a0H et al (2011) The protective effects of levosimendan on ischemia\/reperfusion injury and apoptosis. Recent Pat Cardiovasc Drug Discov 6:20\u201326","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"860_CR35","doi-asserted-by":"publisher","first-page":"9337","DOI":"10.1074\/jbc.M007484200","volume":"276","author":"T Sorsa","year":"2001","unstructured":"Sorsa\u00a0T, Heikkinen\u00a0S, Abbott\u00a0MB et\u00a0al (2001) Binding of levosimendan, a\u00a0calcium sensitizer, to cardiac troponin C. J\u00a0Biol Chem 276:9337\u20139343","journal-title":"J Biol Chem"},{"key":"860_CR36","doi-asserted-by":"publisher","first-page":"20343","DOI":"10.1038\/s41598-019-56831-y","volume":"9","author":"S Terbeck","year":"2019","unstructured":"Terbeck\u00a0S, Heinisch\u00a0PP, Lenz\u00a0A et al (2019) Levosimendan and systemic vascular resistance in cardiac surgery patients: a\u00a0systematic review and meta-analysis. Sci Rep 9:20343","journal-title":"Sci Rep"},{"key":"860_CR37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/bja\/aen367","volume":"102","author":"L Tritapepe","year":"2009","unstructured":"Tritapepe\u00a0L, De Santis\u00a0V, Vitale\u00a0D et al (2009) Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 102:198\u2013204","journal-title":"Br J Anaesth"},{"key":"860_CR38","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/bja\/ael082","volume":"96","author":"L Tritapepe","year":"2006","unstructured":"Tritapepe\u00a0L, De Santis\u00a0V, Vitale\u00a0D et\u00a0al (2006) Preconditioning effects of levosimendan in coronary artery bypass grafting\u2014a pilot study. Br J Anaesth 96:694\u2013700","journal-title":"Br J Anaesth"},{"key":"860_CR39","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1161\/CIRCULATIONAHA.117.029532","volume":"136","author":"S van Diepen","year":"2017","unstructured":"van Diepen\u00a0S, Katz\u00a0JN, Albert\u00a0NM et\u00a0al (2017) Contemporary management of cardiogenic shock: a scientific statement from the American heart association. Circulation 136:e232\u2013e268","journal-title":"Circulation"},{"issue":"6","key":"860_CR40","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.jtcvs.2019.06.020","volume":"159","author":"S van Diepen","year":"2020","unstructured":"van Diepen\u00a0S, Mehta\u00a0RH, Leimberger\u00a0JD et\u00a0al (2020) Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery. J\u00a0Thorac Cardiovasc Surg 159(6):2302\u20132309.e6. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.06.020","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"860_CR41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1055\/s-0039-3400496","volume":"68","author":"C Weber","year":"2020","unstructured":"Weber\u00a0C, Esser\u00a0M, Eghbalzadeh\u00a0K et\u00a0al (2020) Levosimendan reduces mortality and low cardiac output syndrome in cardiac surgery. Thorac Cardiovasc Surg 68(5):401\u2013409. https:\/\/doi.org\/10.1055\/s-0039-3400496","journal-title":"Thorac Cardiovasc Surg"},{"key":"860_CR42","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association (2013) World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310:2191\u20132194","journal-title":"JAMA"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-020-00860-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00101-020-00860-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-020-00860-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T01:13:07Z","timestamp":1633050787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00101-020-00860-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1007\/s00101-020-00860-0","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]},"assertion":[{"value":"25 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Woehrle, L.\u00a0Mehringer, G.\u00a0Juchem, A.\u00a0Dashkevich, M.\u00a0Weis, M.\u00a0Sch\u00fcnemann und E.\u00a0Kilger geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Alle beschriebenen Untersuchungen am Menschen oder an menschlichem Gewebe wurden mit Zustimmung der zust\u00e4ndigen Ethikkommission, im Einklang mit nationalem Recht sowie gem\u00e4\u00df der Deklaration von Helsinki von 1975 (in der aktuellen, \u00fcberarbeiteten Fassung) durchgef\u00fchrt.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}